World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
25256
World Ranking
16588
National Ranking
867

Martin F. Fromm publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Martin F. Fromm sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 234 publications — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Martin F. Fromm D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Martin F. Fromm sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 81 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Martin F. Fromm is affiliated with the University of Erlangen-Nuremberg in Germany and has an extensive publication record in the field of medicine, with a strong emphasis on pharmaceutical sciences and clinical pharmacology. Their research is primarily situated within several specialized subfields including pediatrics, perinatology and child health, molecular biology, oncology, geriatrics and gerontology, and pharmacology. The body of their work spans over 108 publications in medicine, reflecting a multidisciplinary approach.

The research topics covered by Martin F. Fromm focus on pharmaceutical practices and patient outcomes, drug transport and resistance mechanisms, pharmaceutical studies and practices, pharmacological effects and toxicity studies, pharmacovigilance and adverse drug reactions, amino acid enzymes and metabolism, and health systems, economic evaluations, and quality of life. This range shows a comprehensive engagement with both the clinical and molecular aspects of pharmacology and patient care.

The scientist has frequently published in journals such as Clinical Pharmacology & Therapeutics, British Journal of Clinical Pharmacology, Journal of Clinical Medicine, Clinical Chemistry and Laboratory Medicine (CCLM), and Deutsches Ärzteblatt international. The contributions to Clinical Pharmacology & Therapeutics alone total ten publications, highlighting this venue as a significant outlet for their work.

Among recent notable research papers are:

  • The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents (2021), published in Journal of Clinical Oncology
  • Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and Cimetidine (2020), published in Clinical Pharmacokinetics
  • Trimethylamine-N-oxide (TMAO) determined by LC-MS/MS: distribution and correlates in the population-based PopGen cohort (2020), published in Clinical Chemistry and Laboratory Medicine (CCLM)
  • Acod1-mediated inhibition of aerobic glycolysis suppresses osteoclast differentiation and attenuates bone erosion in arthritis (2024), published in Annals of the Rheumatic Diseases
  • Medication Errors During Treatment with New Oral Anticancer Agents: Consequences for Clinical Practice Based on the AMBORA Study (2021), published in Clinical Pharmacology & Therapeutics

Collaborative efforts form an important dimension of their work, with frequent co-authors including Renke Maas, Arne Gessner, Jörg König, Pauline Dürr, and Frank Dörje. The number of co-authored works ranges up to 22 articles with some colleagues, indicating ongoing and sustained scientific partnerships.

Best Publications

  • The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.

    R. B. Kim;M. F. Fromm;C. Wandel;B. Leake

  • Pharmacokinetic interactions with rifampicin : clinical relevance.

    Mikko Niemi;Janne T. Backman;Martin F. Fromm;Pertti J. Neuvonen

  • OATP and P-Glycoprotein Transporters Mediate the Cellular Uptake and Excretion of Fexofenadine

    Mirjana Cvetkovic;Brenda Leake;Martin F. Fromm;Grant R. Wilkinson

  • Importance of P-glycoprotein at blood-tissue barriers.

    Martin F. Fromm

  • Piperine, a Major Constituent of Black Pepper, Inhibits Human P-glycoprotein and CYP3A4

    Rajinder K. Bhardwaj;Hartmut Glaeser;Laurent Becquemont;Ulrich Klotz

  • Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein.

    R. B. Kim;C. Wandel;B. Leake;M. Cvetkovic

  • Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects

    Jörg König;Fabian Müller;Martin F. Fromm

  • Cytochrome P450 2C19 681G>A Polymorphism and High On-Clopidogrel Platelet Reactivity Associated With Adverse 1-Year Clinical Outcome of Elective Percutaneous Coronary Intervention With Drug-Eluting or Bare-Metal Stents

    Dietmar Trenk;Willibald Hochholzer;Martin F. Fromm;Ligia-Emilia Chialda

  • Inhibition of P-Glycoprotein–Mediated Drug Transport A Unifying Mechanism to Explain the Interaction Between Digoxin and Quinidine

    M F Fromm;R B Kim;C M Stein;G R Wilkinson

  • High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1).

    Mikko Niemi;Elke Schaeffeler;Thomas Lang;Martin F Fromm

  • The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells.

    Monika Hitzl;Siegfried Drescher;Heiko Van Der Kuip;Elke Schäffeler

  • P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs.

    Fromm Mf

  • ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin.

    Jenni Keskitalo;O Zolk;Martin F Fromm;Kaisa Kurkinen

  • Pharmacogenomics of human OATP transporters

    Jörg König;Annick Seithel;Ulrike Gradhand;Martin F. Fromm

  • Genetic polymorphisms of the human MDR1 drug transporter

    Matthias Schwab;Michel Eichelbaum;Martin F Fromm

  • Impact of Cytochrome P450 2C19 Loss-of-Function Polymorphism and of Major Demographic Characteristics on Residual Platelet Function After Loading and Maintenance Treatment With Clopidogrel in Patients Undergoing Elective Coronary Stent Placement

    Willibald Hochholzer;Dietmar Trenk;Martin F. Fromm;Christian M. Valina

  • Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis

    Matthias Schwab;Elke Schaeffeler;Claudia Marx;Martin F. Fromm

  • Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene.

    Andreas Johne;Karla Köpke;Thomas Gerloff;Ingrid Mai

  • Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin

    M F Fromm;D Busse;H K Kroemer;M Eichelbaum

  • The effect of rifampin treatment on intestinal expression of human MRP transporters.

    Martin F. Fromm;Hans-Martin Kauffmann;Peter Fritz;Oliver Burk

Frequent Co-Authors

Michel Eichelbaum
Michel Eichelbaum University of Tübingen
Matthias Schwab
Matthias Schwab University of Tübingen
Ute Hofmann
Ute Hofmann University of Tübingen
Heyo K. Kroemer
Heyo K. Kroemer University of Göttingen
Richard B. Kim
Richard B. Kim University of Western Ontario
Mikko Niemi
Mikko Niemi University of Helsinki
Kay Brune
Kay Brune University of Erlangen-Nuremberg
Dan M. Roden
Dan M. Roden Vanderbilt University Medical Center
Grant R. Wilkinson
Grant R. Wilkinson Vanderbilt University
Heinrich Sticht
Heinrich Sticht University of Erlangen-Nuremberg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA opens doors to a variety of online degrees and specialized pathways. Many students are now choosing flexible online options to gain advanced skills and credentials while balancing work and life commitments.

Those interested in mental health can accelerate their studies through the fastest pmhnp program, preparing for the growing demand in psychiatric nurse practitioners. Meanwhile, if you're aiming for a leadership role in healthcare settings, managing costs is crucial—information on healthcare administration degree cost highlights budget-friendly routes available online.

For those seeking advanced management and administrative careers, explore affordable mha online programs that offer quality education at a lower price point. Aspiring to the highest clinical roles? Consider the best online dnp programs to boost your qualifications and impact patient care.

These online degrees are designed to support diverse career goals within healthcare, provide flexibility, and help control educational expenses.

Best Scientists Citing Martin F. Fromm

Trending Scientists